TY - JOUR
T1 - Role of prostaglandins in angiotensin-induced steroidogenesis absence of an effect by prostaglandin e2
AU - Campbell, W. B.
AU - Gomez-Sanchez, C. E.
AU - Adams, B. V.
PY - 1980
Y1 - 1980
N2 - Recently, we have found that tbe prostaglandin synthesis inhibitor, indometfaacin, reduced basal and angiotensin stimulated aldosterone release. To further test tbe possibility that prostaglandins (PGs) function as mediators of adrenal steroidogenesis, we examined the release of aldosterone, PGE2, and PGFtaunder basal and stimulated conditions in isolated adrenal capsular cells in vitro. Angiotensin II and HI caused a dose-related increase in aldosterone release without significantly altering tbe release of PGE, or PGF2. Indomethacin inhibited basal, angiotensin II, and angiotensin Ill-induced steroidogenesis by 40%, 15%, and 52% respectively. Additionally, it inhibited tbe release of PGE, by 60% in the control and angiotendn-treated cells. In indomethacin-treated cells, PGE, stimulated aldosterone release in sapraphysiologic doses; however, its steroidogenlc effect was not additive with angiotensin II. The prostaglandin precursor, arachidonic acid, increased the adrenal synthesis of PGE, and PGFta in a dose-related manner without altering the synthesis of aldosterone. Similarly, the prostaglandin endoperoxide PGH, increased tbe synthesis of PGE, by 250-fold, yet failed to alter aldosterone synthesis. These findings indicate that PGE, does not mediate or modulate basal or angiotensin-stimulated steroidogenesis. Furthermore, it would appear that indomethacin may inhibit adrenal steroidogenesis via a mechanism other than inhibition of prostaglandin synthesis.
AB - Recently, we have found that tbe prostaglandin synthesis inhibitor, indometfaacin, reduced basal and angiotensin stimulated aldosterone release. To further test tbe possibility that prostaglandins (PGs) function as mediators of adrenal steroidogenesis, we examined the release of aldosterone, PGE2, and PGFtaunder basal and stimulated conditions in isolated adrenal capsular cells in vitro. Angiotensin II and HI caused a dose-related increase in aldosterone release without significantly altering tbe release of PGE, or PGF2. Indomethacin inhibited basal, angiotensin II, and angiotensin Ill-induced steroidogenesis by 40%, 15%, and 52% respectively. Additionally, it inhibited tbe release of PGE, by 60% in the control and angiotendn-treated cells. In indomethacin-treated cells, PGE, stimulated aldosterone release in sapraphysiologic doses; however, its steroidogenlc effect was not additive with angiotensin II. The prostaglandin precursor, arachidonic acid, increased the adrenal synthesis of PGE, and PGFta in a dose-related manner without altering the synthesis of aldosterone. Similarly, the prostaglandin endoperoxide PGH, increased tbe synthesis of PGE, by 250-fold, yet failed to alter aldosterone synthesis. These findings indicate that PGE, does not mediate or modulate basal or angiotensin-stimulated steroidogenesis. Furthermore, it would appear that indomethacin may inhibit adrenal steroidogenesis via a mechanism other than inhibition of prostaglandin synthesis.
KW - Angiotensin II
KW - Angiotensin III
KW - Arachidonic acid
KW - Indomethacin
KW - Prostaglandin F
KW - Prostaglandin H
UR - http://www.scopus.com/inward/record.url?scp=0019141078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019141078&partnerID=8YFLogxK
U2 - 10.1161/01.HYP.2.4.471
DO - 10.1161/01.HYP.2.4.471
M3 - Article
C2 - 7399628
AN - SCOPUS:0019141078
SN - 0194-911X
VL - 2
SP - 471
EP - 476
JO - Hypertension
JF - Hypertension
IS - 4
ER -